Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the united states are substantially higher than medicare payments

Clinical Cardiology

Volumn 38, Issue 1, 2015, Pages 13-19

  Afana, Majed ^a   Brinjikji, Waleed ^b   Cloft, Harry ^b   Salka, Samer ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Premier Cardiovascular Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIAGNOSIS RELATED GROUP; FEMALE; HOSPITAL CHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REIMBURSEMENT; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; ACUTE CORONARY SYNDROME; CODING; ECONOMICS; EPIDEMIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; YOUNG ADULT;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; CLINICAL CODING; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICARE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84922646816     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22341     Document Type: Article

References (25)

1. Kochanek KD, Xu JQ, Murphy SL, et al. Deaths: preliminary data for 2009. Natl Vital Stat Rep. 2011;59:1-51.
2. Kolansky DM. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care. 2009;15:S36-S41.
3. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Nationwide Inpatient Sample. 2001-2009. http://www.hcup-us.ahrq.gov/nisoverview.jsp. (accessed December 31, 2012).
4. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Cost-to-charge ratio files. August 2011. http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. (accessed December 31, 2012).
5. Riley RF, Don CW, Powell W, et al. Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes. 2011;4:193-197.
6. Zhao Z, Winget M. Economic burden of illness of acute coronary syndromes: medical and productivity costs. BMC Health Serv Res. 2011;11:35.
7. Ryan J, Linde-Zwirble W, Engelhart L, et al. Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the U.S. Medicare program. Circulation. 2009;119:952-961.
8. Venkitachalam L, Lei Y, Stolker JM, et al. Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation. 2011;124:1028-1037.
9. Brinjikji W, Kallmes DF, Lanzino G, et al. Hospitalization costs for endovascular and surgical treatment of unruptured cerebral aneurysms in the United States are substantially higher than Medicare payments. Am J Neuroradiol. 2012;33:49-51.
10. Brinjikji W, Kallmes DF, Rabinstein AA, et al. Hospitalization costs for patients, with acute ischemic stroke treated with endovascular embolectomy in the United States. Stroke. 2011;42:3271-3273.
11. Shen YC, Wu VY. Reductions in Medicare payments and patient outcomes: an analysis of 5 leading Medicare conditions. Med Care. 2013;51:970-977.
12. Wu VY, Shen YC. The long-term impact of Medicare payment reductions on patient outcomes. National Bureau of Economic Research Working Paper. Cambridge, MA: National Bureau of Economic Research; 2011.
13. Bazzoli GJ, Lindrooth RC, Hasnain-Wynia R, et al. The Balanced Budget Act of 1997 and U.S. hospital operations. Inquiry. 2004;41:401-417.
14. Bazzoli G, Clement J, Lindrooth R, et al. Hospital financial condition and operational decisions related to the quality of hospital care. Med Care Res Rev. 2007;64:148-168.
15. Bazzoli G, Chen H, Zhao M, et al. Hospital financial condition and quality of patient care. Health Econ. 2008;17:977-995.
16. White C, Wu VY. How do hospitals cope with sustained slow growth in Medicare prices? Health Serv Res. 2014;49:11-31.
17. Volpp KG, Konetzka RT, Zhu J, et al. Effect of cuts in Medicare reimbursement on process and outcome of care for acute myocardial infarction patients. Circulation. 2005;112:2268-2275.
18. Seshamani M, Schwartz JS, Volpp KG. The effect of cuts in Medicare reimbursement on hospital mortality. Health Serv Res. 2006;41(3 part 1):683-700.
19. Committee on Energy and Commerce Subcommittee on Health. The estimated effect of the Affordable Care Act on Medicare and Medicaid outlays and total national health care expenditures. Washington, DC: US House of Representatives; 2011.
20. Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff. 2003;3:189-198.
21. Eleid M, Rihal C, Gulati R, et al. Systematic use of transradial PCI in patients with ST-segment elevation myocardial infarction: a call to "arms." JACC Cardiovasc Interv. 2013;6:1145-1148.
22. Komocsi A, Aradi D, Kehl D, et al. Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial Infarction. Arch Med Sci. 2014;10:203-212.
23. Safley DM, Amin AP, House JA, et al. Comparison of costs between transradial and transfemoral percutaneous coronary intervention: a cohort analysis from the Premier research database. Am Heart J. 2013;165:303-309.
24. Amin AP, House JA, Safley DM, et al. Costs of transradial percutaneous coronary intervention. JACC Cardiovasc Interv. 2013;6:827-834.
25. Applegate R, Sacrinty M, Schafer P, et al. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv. 2013;82:E375-E384.